The new UC San Diego-Roche Extending Innovation Network (EIN) program has been launched with selection of its first three research projects at the University of California, San Diego School of Medicine.
A team of scientists, led by researchers at the University of California, San Diego School of Medicine and Zacharon Pharmaceuticals, have developed a simple, reliable test for identifying biomarkers for mucopolysaccharidoses (MPS), a group of inherited metabolic disorders that are currently diagnosed in patients only after symptoms have become serious and the damage possibly irreversible.
A team led by Alan Hemming, MD, transplant surgeon at UC San Diego Health System, has successfully performed the west coast’s first ex-vivo liver resection, a radical procedure to completely remove and reconstruct a diseased liver and re-implant it without any tumors.
Wolfgang H. Dillmann, MD, has been selected as chair of the Department of Medicine at the University of California, San Diego School of Medicine. He has also been named the Helen M. Ranney Endowed Chair, the school's first faculty-funded endowed chair, founded in 1991 in honor of the department’s second chair.
Despite the sluggish economy, San Diego’s research efforts to produce new transportation fuels from algae continue to grow at a rapid pace, generating more than double the number of jobs for local workers in 2011 than were available in the region just two years ago.
The University of California, San Diego School of Medicine TREDS (Training, Research and Education for Driving Safety) program has been awarded a grant from the California Office of Traffic Safety to continue their work on driving safety in older adults.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
